Devonian Health Group (GSD.V) Stock Price

Devonian Health Group Price

OTC·CLOSED
7.10
​
Market closed

Revenue has compounded at 33.0% per year over the past 7 years to 23.59 M CAD. Devonian Health Group's net margin stands at -25.5%, up from -226.9% several years earlier.

Devonian Health Group stock price

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Devonian Health Group business model & stock analysis

Devonian Health Group Inc, based in Montmagny, Quebec, operates in the Health Care sector, specializing in pharmaceuticals. The company develops botanical drugs from plant materials and algae for treating inflammatory-autoimmune diseases such as ulcerative colitis and atopic dermatitis. It also creates value-added dermo-cosmetic products like R-Spinasome and Purgenesis, and distributes pharmaceuticals through a subsidiary. Listed on 9 September 2014, the company employs six full-time staff.

Frequently asked questions about Devonian Health Group

Converted at the current exchange rate, the Devonian Health Group share trades at 4.48 EUR (7.10 CAD).

The revenue cannot currently be calculated for Devonian Health Group.

The profit cannot currently be calculated for Devonian Health Group.

The P/E ratio cannot be calculated for Devonian Health Group at the moment.

The P/S cannot be calculated for Devonian Health Group currently.

The Eulerpool Quality Score for Devonian Health Group is 4/10.

The ISIN of Devonian Health Group is CA2518348834. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The ticker of Devonian Health Group is GSD.V. The ticker symbol is used to trade Devonian Health Group shares on the stock exchange.

Fair ValueTerminal
5.89 CAD
Over-/UndervaluationTerminal
Fairly valued
Sector
Industry
Pharmaceuticals
Number of shares
Employees
Revenue per Employee
3.93 M CAD
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Country
Currency
CAD
Initial public offering
Sep 9, 2014
ISIN
CA2518348834
Cusip
251834107
Market capitalization
19.67 M CADMicro Cap
52-Week Range
PEG
—
P/E ratio
P/Ee
—
P/S
P/Se
—
EV/EBIT
—
P/B Ratio
2.15
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
-65.80 %
Last updated Oct 19, 2026, 3:01 AM

Devonian Health Group Peer Group

Devonian Health Group Ticker

OTC · DVHGF